← back to search

William Rae

AstraZeneca (United Kingdom) · GB
🔎 Find collaborators in Immunology · Cancer Research →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Immunology · Cancer Research
Research interest
Research interests include Immunodeficiency and Autoimmune Disorders, Immune Cell Function and Interaction, T-cell and B-cell Immunology, and NF-κB Signaling Pathways.
h-index
22
citations
1,924
works
51
NIH funding
primary concept
email

Recent publications

IRF2BP2 deficiency: An important form of common variable immunodeficiency with inflammation
Journal of Allergy and Clinical Immunology 2025cited by 4position: middledoi
Immunodeficiency, autoimmunity, and increased risk of B cell malignancy in humans with <i>TRAF3</i> mutations
Science Immunology 2022cited by 40position: firstdoi
Therapeutic options for CTLA-4 insufficiency
Journal of Allergy and Clinical Immunology 2021cited by 118position: middledoi
One Gene, Many Facets: Multiple Immune Pathway Dysregulation in SOCS1 Haploinsufficiency
Frontiers in Immunology 2021cited by 29position: lastdoi
Whole-genome sequencing of a sporadic primary immunodeficiency cohort
Nature 2020cited by 239position: middledoi
Characterization of the clinical and immunologic phenotype and management of 157 individuals with 56 distinct heterozygous NFKB1 mutations
Journal of Allergy and Clinical Immunology 2020cited by 125position: middledoi
Publisher Correction: Whole-genome sequencing of a sporadic primary immunodeficiency cohort
Nature 2020cited by 6position: middledoi
Loss of the interleukin-6 receptor causes immunodeficiency, atopy, and abnormal inflammatory responses
The Journal of Experimental Medicine 2019cited by 204position: middledoi
Disease Evolution and Response to Rapamycin in Activated Phosphoinositide 3-Kinase δ Syndrome: The European Society for Immunodeficiencies-Activated Phosphoinositide 3-Kinase δ Syndrome Registry
Frontiers in Immunology 2018cited by 180position: middledoi
Oral Plasma Kallikrein Inhibitor for Prophylaxis in Hereditary Angioedema
New England Journal of Medicine 2018cited by 113position: middledoi
Evaluation of avoralstat, an oral kallikrein inhibitor, in a Phase 3 hereditary angioedema prophylaxis trial: The <scp>OPuS</scp>‐2 study
Allergy 2018cited by 40position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 1 papers (2021–2021) · 1 papers (2025–2025)Lan‐Sun Chen · University Hospital Heidelberg1 papers (2021–2021)Alexander H. Dalpke · University Hospital Heidelberg1 papers (2021–2021)Isabelle Meyts · KU Leuven1 papers (2025–2025) · 1 papers (2021–2021)Tim Niehues · St. Jude Children's Research Hospital1 papers (2025–2025)João Farela Neves · The University of Texas Southwestern Medical Center1 papers (2025–2025) · 1 papers (2021–2021)Karin Chen · Maimonides Medical Center1 papers (2025–2025)Steven M. Holland · Amsterdam University Medical Centers1 papers (2025–2025) · 1 papers (2025–2025)Michael S. Abers · Kantonsspital Aarau1 papers (2025–2025)Chioma Udemgba · Tulane University1 papers (2025–2025)Leif G. Hanitsch · Berlin Institute of Health at Charité - Universitätsmedizin Berlin1 papers (2025–2025)Emilia Liana Falcone · The University of Texas Southwestern Medical Center1 papers (2025–2025) · 1 papers (2021–2021) · 1 papers (2021–2021)Felix Boschann · Humboldt-Universität zu Berlin1 papers (2021–2021)Jenna Bergerson · National Institute of Allergy and Infectious Diseases1 papers (2025–2025)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Immunology · Cancer Research →